Largest biotech companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech companies ranked by earnings, at SGD 11B, ahead of Amgen (SGD 9.9B) and Biogen (SGD 1.7B). Figures as of 18 Nov 2026, 20:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesSGD 11B
- Median
- -SGD 88.4M
- Combined market value
- SGD 1.08T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | SGD 11B | SGD 271B | SGD 218.46 | 0.49% down | 33% up | ||
| 2 | AmgenAMGN · Health Care | SGD 9.9B | SGD 310.3B | SGD 573.59 | 2.86% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | SGD 1.7B | SGD 47.7B | SGD 323.00 | 0.12% down | 49% up | ||
| 4 | argenxARGX · Health Care | SGD 1.7B | SGD 76.6B | SGD 1,218.41 | 0.28% down | 4% up | ||
| 5 | ExelixisEXEL · Health Care | SGD 1B | SGD 21.6B | SGD 88.46 | 0.15% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | SGD 617.1M | SGD 21.2B | SGD 209.68 | 1.99% down | 20% up | ||
| 7 | QiagenQGEN · Health Care | SGD 547.9M | SGD 13.2B | SGD 63.98 | 0.26% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | SGD 408.6M | SGD 14.1B | SGD 123.80 | 0.04% up | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | SGD 264.1M | SGD 12B | SGD 405.58 | 5.35% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | SGD 234.5M | SGD 14.7B | SGD 93.87 | 0.23% up | 26% up | ||
| 11 | RepligenRGEN · Health Care | SGD 63M | SGD 14.2B | SGD 222.14 | 6.22% up | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -SGD 76.7M | SGD 5.9B | SGD 36.69 | 0.14% down | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -SGD 100.2M | SGD 10.2B | SGD 149.36 | 3.42% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -SGD 207.6M | SGD 9.2B | SGD 103.30 | 1.48% up | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -SGD 296.5M | SGD 8.2B | SGD 126.01 | 0.96% up | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -SGD 401.5M | SGD 13.4B | SGD 156.83 | 0.09% up | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -SGD 453.1M | SGD 9.2B | SGD 8.65 | 7.11% up | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -SGD 487.3M | SGD 7.5B | SGD 61.39 | 5.61% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -SGD 652M | SGD 8.9B | SGD 42.91 | 0.21% up | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -SGD 750M | SGD 5.1B | SGD 52.15 | 0.72% up | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -SGD 988.5M | SGD 12B | SGD 75.54 | 1.38% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -SGD 1.5B | SGD 44.5B | SGD 205.88 | 1.86% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -SGD 1.6B | SGD 26.7B | SGD 107.79 | 1.50% down | 16% down | ||
| 24 | ModernaMRNA · Health Care | -SGD 3.6B | SGD 103.1B | SGD 254.90 | 4.41% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2895 SGD).
Questions and answers
Which biotech companies rank first by earnings?
Gilead Sciences (SGD 11B), Amgen (SGD 9.9B) and Biogen (SGD 1.7B) are the top three of the 24 biotech companies ranked by earnings as of 18 Nov 2026, 20:24 UTC.
How many biotech companies are in this ranking?
24 are ranked by earnings.
What are these biotech companies worth together?
The 24 biotech companies ranked by earnings have a combined market value of SGD 1.08T as of 18 Nov 2026, 20:24 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.